Johnston R UO, Cummins E, Clar C, Royle P, Colquitt J, Tan B K, Clegg A, Shantikumar S, Court R, O’Hare J P, McGrane D, Holt T & Waugh N. Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation. Health Technology Assessment 2017;21

https://www.journalslibrary.nihr.ac.uk/hta/hta21020#/full-report